Roubaix Capital’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-54,555
Closed -$6.43M 62
2026
Q1
$6.43M Buy
+54,555
New +$7.62M 3% 9
2025
Q3
Sell
-26,459
Closed -$3.29M 67
2025
Q2
$3.29M Sell
26,459
-8,412
-24% -$1.07M 1.58% 31
2025
Q1
$4.44M Buy
+34,871
New +$5.37M 2.31% 18
2024
Q3
Sell
-14,020
Closed -$1.77M 61
2024
Q2
$1.77M Buy
+14,020
New +$2.2M 1.12% 39

Other funds holding RGEN

Roubaix Capital's RGEN Position: Q2 2026 in Review

Roubaix Capital sold out of Repligen (RGEN) in Q2 2026, closing a stake of 54,555 shares — an estimated $6.43M sold.

Roubaix Capital first reported a position in RGEN in Q2 2024 and held it in 4 quarters. The position peaked at $6.43M in Q1 2026. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Roubaix Capital reported no remaining Repligen position as of Q2 2026 after selling out during the quarter.
  • Roubaix Capital sold 54,555 Repligen shares in Q2 2026, an estimated $6.43M.
  • Roubaix Capital first reported a position in Repligen in Q2 2024 and held it in 4 quarters.
  • Roubaix Capital's Repligen position peaked at $6.43M in Q1 2026.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Roubaix Capital's 13F filing for Q2 2026, filed 10 Aug 2026.